TY - JOUR
T1 - Continuing versus Stopping Prestroke Antihypertensive Therapy in Acute Intracerebral Hemorrhage: A Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke Trial
AU - Krishnan, K.
AU - Scutt, P.
AU - Woodhouse, L.
AU - Adami, A.
AU - Becker, J.L.
AU - Cala, Lesley
AU - Casado, A.M.
AU - Chen, C.
AU - Dineen, R.A.
AU - Gommans, J.
AU - Koumellis, P.
AU - Christensen, H.
AU - Collins, R.
AU - Czlonkowska, A.
AU - Lees, K.R.
AU - Ntaios, G.
AU - Ozturk, S.
AU - Phillips, S.J.
AU - Sprigg, N.
AU - Szatmari, S.
AU - Wardlaw, J.M.
AU - Bath, P.M.
PY - 2016/5/1
Y1 - 2016/5/1
N2 - © 2016 The Authors.Background and purpose More than 50% of patients with acute intracerebral hemorrhage (ICH) are taking antihypertensive drugs before ictus. Although antihypertensive therapy should be given long term for secondary prevention, whether to continue or stop such treatment during the acute phase of ICH remains unclear, a question that was addressed in the Efficacy of Nitric Oxide in Stroke (ENOS) trial. Methods ENOS was an international multicenter, prospective, randomized, blinded endpoint trial. Among 629 patients with ICH and systolic blood pressure between 140 and 220 mmHg, 246 patients who were taking antihypertensive drugs were assigned to continue (n = 119) or to stop (n = 127) taking drugs temporarily for 7 days. The primary outcome was the modified Rankin Score at 90 days. Secondary outcomes included death, length of stay in hospital, discharge destination, activities of daily living, mood, cognition, and quality of life. Results Blood pressure level (baseline 171/92 mmHg) fell in both groups but was significantly lower at 7 days in those patients assigned to continue antihypertensive drugs (difference 9.4/3.5 mmHg, P
AB - © 2016 The Authors.Background and purpose More than 50% of patients with acute intracerebral hemorrhage (ICH) are taking antihypertensive drugs before ictus. Although antihypertensive therapy should be given long term for secondary prevention, whether to continue or stop such treatment during the acute phase of ICH remains unclear, a question that was addressed in the Efficacy of Nitric Oxide in Stroke (ENOS) trial. Methods ENOS was an international multicenter, prospective, randomized, blinded endpoint trial. Among 629 patients with ICH and systolic blood pressure between 140 and 220 mmHg, 246 patients who were taking antihypertensive drugs were assigned to continue (n = 119) or to stop (n = 127) taking drugs temporarily for 7 days. The primary outcome was the modified Rankin Score at 90 days. Secondary outcomes included death, length of stay in hospital, discharge destination, activities of daily living, mood, cognition, and quality of life. Results Blood pressure level (baseline 171/92 mmHg) fell in both groups but was significantly lower at 7 days in those patients assigned to continue antihypertensive drugs (difference 9.4/3.5 mmHg, P
UR - https://www.scopus.com/pages/publications/84957092952
U2 - 10.1016/j.jstrokecerebrovasdis.2016.01.010
DO - 10.1016/j.jstrokecerebrovasdis.2016.01.010
M3 - Article
C2 - 26853137
SN - 1052-3057
VL - 25
SP - 1017
EP - 1026
JO - Journal of Stroke and Cerebrovascular Diseases
JF - Journal of Stroke and Cerebrovascular Diseases
IS - 5
ER -
